Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | UBE2T |
| Upstream (Parents) |
|---|
| (<<) CKS1B → UBE2T |
| (<<) NEK2 → UBE2T |
| (<<) MAD2L1 → UBE2T |
| (<<) KIF2C → UBE2T |
| (<<) EXOSC2 → UBE2T |
| (<<) TBCE → UBE2T |
| Downstream (Children) |
|---|
| UBE2T → PAICS (>>) |
| UBE2T → EXOSC3 (>>) |
| UBE2T → PRPF3 (>>) |
| UBE2T → CKS1B (>>) |
| UBE2T → TAF1A (>>) |
| UBE2T → TSPAN5 (>>) |
| UBE2T → POLR3K (>>) |
| UBE2T → RNASEH2A (>>) |
| UBE2T → JMJD4 (>>) |
| UBE2T → DKC1 (>>) |
| UBE2T → UCHL5 (>>) |
| UBE2T → C12orf48 (>>) |
| UBE2T → GAL (>>) |
| UBE2T → NEK2 (>>) |
| UBE2T → MAD2L1 (>>) |
| UBE2T → CHRNA5 (>>) |
| UBE2T → MND1 (>>) |
| UBE2T → KLRG2 (>>) |
| UBE2T → MCM4 (>>) |
| UBE2T → TBCE (>>) |
| UBE2T → ESRP1 (>>) |
| UBE2T → RFC3 (>>) |
| UBE2T → SIDT2 (>>) |
| UBE2T → MRPL13 (>>) |
| UBE2T → ASF1A (>>) |
| UBE2T → CENPL (>>) |
| UBE2T → CHST15 (>>) |
